News | Contrast Media | November 29, 2015

Guerbet board of directors approves 100 percent acquisition of Mallinckrodt division for $270 million

November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery systems" (CMDS) business of Mallinckrodt. The new entity brings together 2,500 employees, with a pro forma turnover of about €800M.

Guerbet’s board of directors approved the acquisition of the CMDS activity of Mallinckrodt on November 18.

The transaction has all necessary regulatory approvals and the customary closing conditions have been met.

Guerbet is acquiring 100 percent of the Mallinckrodt CMDS business for $270M total, paid in cash and financed by a loan syndicated by BNP Paribas. The acquisition relates to companies with their production sites, intellectual property rights and distribution subsidiaries in the various geographical areas. 

The complementary strengths of Guerbet and CMDS promise to bring rapid benefits, according to both companies: 

The strengths of Guerbet and CMDS will complement each other in several areas, according to the companies:

  • In contrast agents, where CMDS features Optiray and Optiject (Europe) / Ultraject (USA) in X-rays, and Guerbet offers Dotarem in magnetic resonance imaging (MRI);
     
  • In Imaging Solutions and Services, with CMDS’ syringe-based delivery systems and Guerbet’s  hydraulic injection technique for soft bags; and
     
  • From a geographical perspective, a similar synergy exists with a strong position of CMDS in the United States and Guerbet in Europe. In addition, Guerbet will strengthen its presence on markets with high growth potential, particularly in China, Russia, and Turkey.

In the medium-term, the group will achieve significant economies of scale, particularly by using the existing infrastructure and commercial networks to sell new products:

  • By pooling R&D and marketing resources;
  • By optimizing the purchasing, logistics and general spending policies of the two entities.

For more information: www.guerbet.com

Related Content

Feature | Radiology Business | Melinda Taschetta-Millane

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

Time November 02, 2021
arrow
News | Ultrasound Imaging

October 5, 2021 — Ultrasound experts urged the health care community to work to expand utilization of ultrasound ...

Time October 05, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Contrast Media Injectors

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

Time September 16, 2021
arrow
News | PET-CT

August 4, 2021 — PET/CT systems are expected to continue to incorporate the highest clinical performance of PET as well ...

Time August 04, 2021
arrow
News | Contrast Media

July 30, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), the resources required to warm iohexol 350 ...

Time July 30, 2021
arrow
News | Contrast Media

June 30, 2021 – IQ-AI subsidiary Imaging Biometrics (IB) was awarded a U.S. patent for its artificial intelligence (AI) ...

Time June 30, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 ...

Time May 12, 2021
arrow
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Time May 11, 2021
arrow
News | Contrast Media

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

Time May 03, 2021
arrow
Subscribe Now